10,021 Shares in STERIS plc $STE Bought by Elo Mutual Pension Insurance Co

Elo Mutual Pension Insurance Co bought a new stake in STERIS plc (NYSE:STE) during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 10,021 shares of the medical equipment provider’s stock, valued at approximately $2,480,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the company. Steigerwald Gordon & Koch Inc. acquired a new stake in shares of STERIS in the 3rd quarter worth about $25,000. Spurstone Advisory Services LLC bought a new position in STERIS in the 2nd quarter worth about $29,000. Cloud Capital Management LLC acquired a new stake in shares of STERIS in the third quarter valued at approximately $29,000. Geneos Wealth Management Inc. increased its stake in shares of STERIS by 416.0% in the first quarter. Geneos Wealth Management Inc. now owns 129 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 104 shares during the period. Finally, TruNorth Capital Management LLC bought a new stake in shares of STERIS during the third quarter valued at approximately $37,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Price Performance

Shares of NYSE:STE opened at $243.37 on Thursday. The stock has a market cap of $23.87 billion, a price-to-earnings ratio of 33.94 and a beta of 1.05. The company has a debt-to-equity ratio of 0.26, a current ratio of 2.48 and a quick ratio of 1.75. STERIS plc has a 12 month low of $204.90 and a 12 month high of $269.44. The stock’s 50 day moving average price is $255.21 and its 200 day moving average price is $251.70.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.During the same quarter last year, the company posted $2.32 earnings per share. The company’s quarterly revenue was up 9.2% on a year-over-year basis. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities research analysts anticipate that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, March 19th. Shareholders of record on Tuesday, February 17th will be issued a $0.63 dividend. This represents a $2.52 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date of this dividend is Tuesday, February 17th. STERIS’s dividend payout ratio is presently 35.15%.

Analyst Ratings Changes

A number of equities analysts recently issued reports on STE shares. Wall Street Zen lowered STERIS from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of STERIS in a research report on Friday, January 9th. Six investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $275.20.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.